[Therapeutic action of IB-503 evaluated on the strength of the author's 4-year clinical experience].
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D003508:Cycloheptanes / Q000008:administration & dosage / Q000627:therapeutic use; D003863:Depression / Q000188:drug therapy*; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D008744:Methylamines / Q000008:administration & dosage / Q000627:therapeutic use; D008875:Middle Aged; D011618:Psychotic Disorders / Q000188:drug therapy*; D013876:Thiophenes / Q000008:administration & dosage / Q000627:therapeutic use*
D003508:Cycloheptanes; D008744:Methylamines; D013876:Thiophenes
Ocena wartości leczneczej przetworu "IB-503" na podstawie własnych czteroletnich doświadczeń klinicznych.